Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Is januvia still on the market?Lipitor vs generics what's the price gap?How to apply for vascepa's patient assistance?Quartette side effects?
See the DrugPatentWatch profile for ivermectin
This response is based on information available regarding ivermectin. It is important to note that the U.S. Food and Drug Administration (FDA) has not approved ivermectin for the treatment or prevention of COVID-19 in adults.
Ivermectin is an FDA-approved medication used to treat parasitic infections in both humans and animals. In humans, it is prescribed for conditions such as river blindness (onchocerciasis), intestinal strongyloidiasis, and scabies [1]. It is also used to treat head lice [1].
The FDA has not approved ivermectin for use in preventing or treating COVID-19 [2]. While some studies have explored its potential, the available scientific evidence does not support its use for this purpose [2]. The FDA advises against using ivermectin products intended for veterinary use in humans [2].
Information regarding drug patents, patent expiration dates, and market exclusivity can be found on DrugPatentWatch.com [3]. This resource tracks patent information for pharmaceuticals, which is crucial for understanding when generic versions of a drug might become available.
Other Questions About Ivermectin :